Global Circulating Tumor Cell Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 4007

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The classification of Circulating Tumor Cells (CTCs) products includes CTC enrichment, CTC detection and CTC analysis, and the revenue proportion of CTC enrichment in 2016 is about 43.74%.
In 2018, the global Circulating Tumor Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Circulating Tumor Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Circulating Tumor Cell development in United States, Europe and China.

The key players covered in this study
Menarini-Silicon Biosystems
Qiagen(Adnagen)
Clearbridge Biomedics
Celsee
Fluidigm
ApoCell
Greiner Bio-one GmbH
Advanced Cell Diagnostics
Aviva Biosciences
Fluxion Biosciences
Sysmex Corporation
Epic Sciences
Cynvenio
CytoTrack
Ikonisys
Vortex BioSciences
Gilupi
Biocept
ScreenCell
ANGLE

Market segment by Type, the product can be split into
CTC Enrichment
CTC Detection
CTC Analysis

Market segment by Application, split into
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Circulating Tumor Cell status, future forecast, growth opportunity, key market and key players.
To present the Circulating Tumor Cell development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Circulating Tumor Cell are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Circulating Tumor Cell Market Size Growth Rate by Type (2014-2025)
1.4.2 CTC Enrichment
1.4.3 CTC Detection
1.4.4 CTC Analysis
1.5 Market by Application
1.5.1 Global Circulating Tumor Cell Market Share by Application (2014-2025)
1.5.2 Breast Cancer
1.5.3 Prostate Cancer
1.5.4 Colorectal Cancer
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Circulating Tumor Cell Market Size
2.2 Circulating Tumor Cell Growth Trends by Regions
2.2.1 Circulating Tumor Cell Market Size by Regions (2014-2025)
2.2.2 Circulating Tumor Cell Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Circulating Tumor Cell Market Size by Manufacturers
3.1.1 Global Circulating Tumor Cell Revenue by Manufacturers (2014-2019)
3.1.2 Global Circulating Tumor Cell Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Circulating Tumor Cell Market Concentration Ratio (CR5 and HHI)
3.2 Circulating Tumor Cell Key Players Head office and Area Served
3.3 Key Players Circulating Tumor Cell Product/Solution/Service
3.4 Date of Enter into Circulating Tumor Cell Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Circulating Tumor Cell Market Size by Type (2014-2019)
4.2 Global Circulating Tumor Cell Market Size by Application (2014-2019)

5 United States
5.1 United States Circulating Tumor Cell Market Size (2014-2019)
5.2 Circulating Tumor Cell Key Players in United States
5.3 United States Circulating Tumor Cell Market Size by Type
5.4 United States Circulating Tumor Cell Market Size by Application

6 Europe
6.1 Europe Circulating Tumor Cell Market Size (2014-2019)
6.2 Circulating Tumor Cell Key Players in Europe
6.3 Europe Circulating Tumor Cell Market Size by Type
6.4 Europe Circulating Tumor Cell Market Size by Application

7 China
7.1 China Circulating Tumor Cell Market Size (2014-2019)
7.2 Circulating Tumor Cell Key Players in China
7.3 China Circulating Tumor Cell Market Size by Type
7.4 China Circulating Tumor Cell Market Size by Application

8 Japan
8.1 Japan Circulating Tumor Cell Market Size (2014-2019)
8.2 Circulating Tumor Cell Key Players in Japan
8.3 Japan Circulating Tumor Cell Market Size by Type
8.4 Japan Circulating Tumor Cell Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Circulating Tumor Cell Market Size (2014-2019)
9.2 Circulating Tumor Cell Key Players in Southeast Asia
9.3 Southeast Asia Circulating Tumor Cell Market Size by Type
9.4 Southeast Asia Circulating Tumor Cell Market Size by Application

10 India
10.1 India Circulating Tumor Cell Market Size (2014-2019)
10.2 Circulating Tumor Cell Key Players in India
10.3 India Circulating Tumor Cell Market Size by Type
10.4 India Circulating Tumor Cell Market Size by Application

11 Central & South America
11.1 Central & South America Circulating Tumor Cell Market Size (2014-2019)
11.2 Circulating Tumor Cell Key Players in Central & South America
11.3 Central & South America Circulating Tumor Cell Market Size by Type
11.4 Central & South America Circulating Tumor Cell Market Size by Application

12 International Players Profiles
12.1 Menarini-Silicon Biosystems
12.1.1 Menarini-Silicon Biosystems Company Details
12.1.2 Company Description and Business Overview
12.1.3 Circulating Tumor Cell Introduction
12.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cell Business (2014-2019)
12.1.5 Menarini-Silicon Biosystems Recent Development
12.2 Qiagen(Adnagen)
12.2.1 Qiagen(Adnagen) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Circulating Tumor Cell Introduction
12.2.4 Qiagen(Adnagen) Revenue in Circulating Tumor Cell Business (2014-2019)
12.2.5 Qiagen(Adnagen) Recent Development
12.3 Clearbridge Biomedics
12.3.1 Clearbridge Biomedics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Circulating Tumor Cell Introduction
12.3.4 Clearbridge Biomedics Revenue in Circulating Tumor Cell Business (2014-2019)
12.3.5 Clearbridge Biomedics Recent Development
12.4 Celsee
12.4.1 Celsee Company Details
12.4.2 Company Description and Business Overview
12.4.3 Circulating Tumor Cell Introduction
12.4.4 Celsee Revenue in Circulating Tumor Cell Business (2014-2019)
12.4.5 Celsee Recent Development
12.5 Fluidigm
12.5.1 Fluidigm Company Details
12.5.2 Company Description and Business Overview
12.5.3 Circulating Tumor Cell Introduction
12.5.4 Fluidigm Revenue in Circulating Tumor Cell Business (2014-2019)
12.5.5 Fluidigm Recent Development
12.6 ApoCell
12.6.1 ApoCell Company Details
12.6.2 Company Description and Business Overview
12.6.3 Circulating Tumor Cell Introduction
12.6.4 ApoCell Revenue in Circulating Tumor Cell Business (2014-2019)
12.6.5 ApoCell Recent Development
12.7 Greiner Bio-one GmbH
12.7.1 Greiner Bio-one GmbH Company Details
12.7.2 Company Description and Business Overview
12.7.3 Circulating Tumor Cell Introduction
12.7.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cell Business (2014-2019)
12.7.5 Greiner Bio-one GmbH Recent Development
12.8 Advanced Cell Diagnostics
12.8.1 Advanced Cell Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Circulating Tumor Cell Introduction
12.8.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cell Business (2014-2019)
12.8.5 Advanced Cell Diagnostics Recent Development
12.9 Aviva Biosciences
12.9.1 Aviva Biosciences Company Details
12.9.2 Company Description and Business Overview
12.9.3 Circulating Tumor Cell Introduction
12.9.4 Aviva Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)
12.9.5 Aviva Biosciences Recent Development
12.10 Fluxion Biosciences
12.10.1 Fluxion Biosciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Circulating Tumor Cell Introduction
12.10.4 Fluxion Biosciences Revenue in Circulating Tumor Cell Business (2014-2019)
12.10.5 Fluxion Biosciences Recent Development
12.11 Sysmex Corporation
12.12 Epic Sciences
12.13 Cynvenio
12.14 CytoTrack
12.15 Ikonisys
12.16 Vortex BioSciences
12.17 Gilupi
12.18 Biocept
12.19 ScreenCell
12.20 ANGLE

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details